Therapeutic Drug Monitoring of Suramin and Protein Binding

References

• Spigelman , Z. , Dowers , A. , Kennedy , S. , Disorbo , D. , O'Brien , M. , Barr , R. and McCaffrey , R. 1987 . Antiproliferative Effects of Suramin of Lymphoid Cells . Cancer Res. , 47 : 4694 – 4698 .
   PubMedGoogle Scholar
• Garrett , J. , Coughlin , S. , Niman , H. L. , Tremble , P. M. , Giels , G. M. and Williams , L. T. 1984 . Blockade of Autocrine Stimulation in Simian Sarcoma Virus Transformed Cell Reverses Down-regulation of Platelet-derived Growth Factor Receptors . Proc. Natl. Acad. Sci. U.S.A. , 81 : 7466 – 7470 .
   PubMed Web of Science ®Google Scholar
• Betsholtz , C. , Johnsson , A. , Heldin , C. and Westermark , B. 1986 . Efficient reversion of simian sarcoma virus-transformation and inhibition of growth factor-induced mitogenesis by suramin . Proc. Natl. Acad. Sci. U.S.A. , 83 : 6440 – 6444 .
   PubMed Web of Science ®Google Scholar
• Coffey , R. J. , Leof , E. B. , Shipley , G. D. and Moses , H. L. 1987 . Suramin inhibition of growth factor receptor binding and mitogenicity in AKR-2B cells . J. cell. Phys. , 132 : 143 – 148 .
   PubMed Web of Science ®Google Scholar
• Constantopoulos , G. , Rees , S. , Cragg , B. , Barranger , J. A. and Brady , R. O. 1980 . Experimental animal model for mucopolysaccharidosis: Suramin-induced glycosaminoglycan and sphingolipid accumulation in the rat . Proc. Natl. Acad. Sci. U.S.A. , 77 : 3700 – 3704 .
   PubMed Web of Science ®Google Scholar
• Folkman , J. and Klagsbrun , M. 1987 . Angiogenic Factors . Science , 235 : 442 – 447 .
   PubMed Web of Science ®Google Scholar
• Fujita , M. , Spray , D. and Choi , H. 1987 . Glycosaminoglycans and proteoglycans induce gap junction expression and restore transcription of tissue-specific mRNA's in primary liver cultures . Hepatology , 7 : 1 – 9 .
   PubMed Web of Science ®Google Scholar
• Jindal , M. K. , Anderson , C. W. , Davis , R. G. and Vishwanatha , J. K. 1990 . Suramin Affects DNA Synthesis in HeLa Cells by Inhibition of DNA Polymerases . Cancer Res. , 50 : 7754 – 7757 .
   PubMed Web of Science ®Google Scholar
• Myers , C. , Stein , C. , La Rocca , R. and Cooper , M. In: Abstracts of the Sixth NCI-EORTC Symposium on New Drugs in Cancer Therapy . pp. 152
   Google Scholar
• van Oosterom , Eric A. T. , De Smedt , Louis A. , Denis Ernst , J. , de Bruijn , A. and Mahler , C. 1990 . Suramin for Prostatic Cancer: a Phase I/II Study in Advanced Extensively Pretreated Disease . Eur. J. Cancer , 26 : 422
   Google Scholar
• Klecker , R. W. and Collins , J. M. 1985 . Quantification of Suramin by Reverse-phase Ion Pairing High-Performance Liquid Chromatography . J. Liq. Chromatogr. , 8 : 1685 – 1996 .
   Web of Science ®Google Scholar
• Edwards , G. , Rodick , G. L. and Ward , S. A. 1985 . Determination of suramin in plasma by High-Performance Liquid Chromatography . J. Chromatogr. , 343 : 224 – 228 .
   PubMedGoogle Scholar
• Ruprecht , R. M. , Lorsch , J. and Trites , D. H. 1986 . Analysis of Suramin Plasma Levels by ion-pair high-performance liquid chromatography under isocratic conditions . J. Chromatogr. , 378 : 498 – 502 .
   PubMedGoogle Scholar
• Teirlynck , O. , Bogaert , M. G. , Demedts , P. and Taelman , H. 1989 . Rapid high-performance liquid chromatographic determination of suramin in plasma of patients with acquired immune deficiency syndrome (AIDS) or AIDS-related complex (ARC) . J. Pharm. Biomed. Anal. , 7 : 123 – 126 .
   Google Scholar
• Tjaden , U. R. , Reeuwijk , H. J. E. M. , van der Greef , J. , Pattyn , G. , de Bruijn , E. A. and van Oosterom , A. T. 1990 . Bioanalysis of Suramin in Human Plasma by Ion-Pair High Performance Liquid Chromatography . J. Chromatogr. , 525 : 141 – 149 .
   Google Scholar
• Supko , J. G. and Malspeis , L. 1990 . A rapid isocratic HPLC assay of Suramin (NSC 34936) in human plasma . J. Liq. Chromaogr. , 13 ( 4 ) : 727 – 741 .
   Web of Science ®Google Scholar
• Allolio , B. , Reincke , M. , Arlt , W. , Deuss , U. , Winkelmann , W. and Siekmann , L. 1989 . Suramin for Treatment of Adrenocortical Carcinoma . Lancet , II : 277
   Google Scholar
• de Bruijn , E. A. 1991 . Clinical Pharmacokinetics of suramin and influence of Protein Binding Submitted for publication
   Google Scholar
• Collins , J. M. , Klecker , R. W. , Yarchoan , R. , Lane , H. C. , Fauci , A. S. , Redfield , R. R. , Broder , S. B. and Myers , C. E. 1986 . Clinical Pharmacokinetics of Suramin in Patients with HTLV.III/LAV Infection . J. Clin. Pharmacol. , 26 : 22 – 26 .
   PubMedGoogle Scholar
• Feuillan , P. , Raffeld , M. , Stein , C. A. , Lipford , N. , Rehnquist , D. , Myers , C. E. , La Rocca , R. V. and Chrousos , G. P. 1987 . Effects of Suramin on the Function and Structure of the Adrenal Cortex in the Cynomolgus Monkey . J. Endocrin. Metab. , 65 : 153 – 158 .
   Google Scholar
• Koch-Weser , J. and Sellers , E. M. 1976 . Binding of Drugs to Serum Albumin (First of Two Parts) . N. Engl. J. Med. , 294 : 311 – 316 .
   PubMed Web of Science ®Google Scholar
• Koch-Weser , J. and Sellers , E. M. 1976 . Binding of Drugs to Serum Albumin (Second of Two Parts) . N. Engl. J. Med. , 294 : 526 – 531 .
   PubMed Web of Science ®Google Scholar